- Report
- May 2026
- 350 Pages
Global
From €4490EUR$4,949USD£3,870GBP
- Report
- May 2026
- 350 Pages
Global
From €4490EUR$4,949USD£3,870GBP
- Report
- May 2026
- 400 Pages
Global
From €4490EUR$4,949USD£3,870GBP
- Report
- May 2026
- 400 Pages
Global
From €4490EUR$4,949USD£3,870GBP
- Report
- May 2026
- 400 Pages
Global
From €4490EUR$4,949USD£3,870GBP
- Report
- September 2025
- 150 Pages
Global
From €4037EUR$4,450USD£3,479GBP
- Report
- September 2025
- 150 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- August 2025
- 150 Pages
Global
From €4400EUR$4,850USD£3,792GBP
- Report
- May 2026
- 165 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 156 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 165 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 154 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 150 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 145 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 158 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- May 2026
- 148 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- April 2026
- 157 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- April 2026
- 154 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- January 2026
- 140 Pages
Global
From €3584EUR$3,950USD£3,088GBP
- Report
- August 2025
- 147 Pages
Global
From €3584EUR$3,950USD£3,088GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more